Fundraising FoxEvidity Health Capital — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
bioTheranosticsbiotheranostics.cominJan 2016
Biotheranostics develops proprietary genomic assays used to support personalized disease management in oncology.
BiotechHealthtechMedical DevicesSan Diego, US
Nicholas Barthelemy(Executive Officer, Director, Promoter)
BoardDavid Kabakoff(Director)inEric Bednarski(Director)Alejandro Sanchez(Director)in
Co-investorsHealthQuest CapitalMVM Life Science Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.